Anastasia Zherlitsyna — timeline

Metastatic GIST (initially diagnosed as uterine leiomyosarcoma), Kyiv, Ukraine · records 2022–2026 · updated 14 Oct 2026

← labs and other records

Tumour markers CA-125 and HE-4, Oct 2022

Date: 2022-10-24   Category: lab   Language: en
Drive path: en_tests/[blood] Antibodies_markers.docx

Links: this document on Google Drive [hosted copy]
Summary: English-translated laboratory results for ovarian-cancer markers CA-125 and HE-4 from 3 and 24 October 2022.
Date Test name Result Units
24.10.2022 Marker of ovarian cancer СА 125 244.80* U/mL
24.10.2022 Early marker of ovarian cancer HE-4 71.9* pmol/L
03.10.2022 Marker of ovarian cancer СА 125 216.50* U/mL
03.10.2022 Early marker of ovarian cancer HE-4 60.3 pmol/L
16.09.2022 Antibodies to Treponema pallidum

0.31

negative

 Index
16.09.2022 Antibodies to hepatitis C virus - screening (Anti-HCV)

0.05

negative

 Index
25.08.2022 Marker of ovarian cancer СА 125 93.60* U/mL
25.08.2022 Early marker of ovarian cancer HE-4 77.9* pmol/L
25.08.2022 Antibodies to Treponema pallidum

0.35

negative

 Index
25.08.2022 Hepatitis B HBSAg

0.19

negative

 S/CO
25.08.2022 Antibodies to hepatitis C virus - screening (Anti-HCV)

0.10

negative

 Index